TransCode Therapeutics In...

0.46
-0.07 (-12.96%)
At close: Apr 03, 2025, 3:59 PM
0.45
-3.57%
After-hours: Apr 03, 2025, 07:59 PM EDT

TransCode Therapeutics Stock Forecast

Stock Price Forecast

The 1 analysts with 12-month price forecasts for RNAZ stock have an median target of 20, with a low estimate of 20 and a high estimate of 20. The median target predicts an increase of 4247.83% from the current stock price of 0.46.

Target Low Average Median High
Price $20 $20 $20 $20
Change 4247.83% 4247.83% 4247.83% 4247.83%

Latest Analyst Insight Report

HC Wainwright & Co. maintains a Buy rating on Tran... Unlock content with Pro Subscription

Updated Mar 13, 2025

Rating Sep 24Oct 24Nov 24Dec 24Feb 25Mar 25
Strong Buy 000100
Buy 111021
Hold 000000
Sell 000000
Strong Sell 000000
Total 1 1 1 1 2 1

Financial Forecast this Year

Revenue This Year
300K
from 0
Increased by -%
Revenue Next Year
1M
from 300K
Increased by 233.3%
EPS This Year
-157.08
from -103.61
Increased by -51.6%
EPS Next Year
-144.21
from -157.08
Increased by 8.2%